Syquant Capital SAS’s STAAR Surgical STAA Stock Holding History

Syquant Capital SAS’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-800	Closed	-$122K	–	53
2021 Q2	$122K	Buy	+800	New	+$105K	0.15%	37

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Syquant Capital SAS's STAA Position: Q3 2021 in Review

Syquant Capital SAS sold out of STAAR Surgical (STAA) in Q3 2021, closing a stake of 800 shares — an estimated $122K sold.

Syquant Capital SAS first reported a position in STAA in Q2 2021 and held it in 1 quarter. The position peaked at $122K in Q2 2021. 290 funds tracked by Wall St. Rank hold STAA as of Q3 2021.

Syquant Capital SAS reported no remaining STAAR Surgical position as of Q3 2021 after selling out during the quarter.
Syquant Capital SAS sold 800 STAAR Surgical shares in Q3 2021, an estimated $122K.
Syquant Capital SAS first reported a position in STAAR Surgical in Q2 2021 and held it in 1 quarter.
Syquant Capital SAS's STAAR Surgical position peaked at $122K in Q2 2021.
290 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2021.

Based on Syquant Capital SAS's 13F filing for Q3 2021, filed 14 Oct 2021.